Package Leaflet - Information for the User. TOBRADEX 3 mg/ml/1 mg/ml Eye Drops, Suspension Tobramycin and Dexamethasone

Similar documents
Package leaflet: Information for the user. NEVANAC 1 mg/ml eye drops, suspension Nepafenac

IOPIDINE 5mg/ml Eye Drops, solution contain apraclonidine (as hydrochloride) as the active substance.

Package Leaflet: Information for the user. NEVANAC 3 mg/ml eye drops, suspension nepafenac

PRED FORTE 1% w/v Eye Drops, Suspension Prednisolone acetate

Package leaflet: Information for the user Oftaquix 5 mg/ml eye drops, solution. Levofloxacin

Package leaflet: Information for the user. AZOPT 10 mg/ml eye drops, suspension Brinzolamide

Package leaflet: Information for the user. PRED MILD STERILE OPHTHALMIC SUSPENSION 0.12% w/v Eye Drops, Suspension Prednisolone Acetate

PACKAGE LEAFLET: INFORMATION FOR THE USER ACULAR 0.5% w/v EYE DROPS, SOLUTION (Ketorolac trometamol)

Proposed PIL NL/H/0653/001/IB/024/G. MONOFREE DEXAMETHASON 1 mg/ml, eye drops, solution in single-dose container Dexamethasone phosphate

Package leaflet: Information for the user. <product name> 3 mg/ml eye drops, solution. Ofloxacin

Dorzolamide 20 mg/ml Eye Drops, Solution

Package leaflet: Information for the user. Carmellose sodium

Package leaflet: Information for the patient. IKERVIS 1 mg/ml, eye drops, emulsion ciclosporin

Package leaflet: Information for the user. Relestat, 0.5 mg/ml, eye drops, solution Epinastine hydrochloride

Package leaflet: Information for the patient. Brimonidine Biogaran 2 mg/ml eye drops, solution. brimonidine tartrate

MAXIDEX Eye Drops 0.1%

TOBRADEX TM Eye Drops

Package leaflet: Information for the patient. Verkazia 1 mg/ml eye drops emulsion ciclosporin

Package Leaflet: Information for the user. LUMIGAN 0.3 mg/ml, eye drops, solution, in single-dose container Bimatoprost

PACKAGE LEAFLET: INFORMATION FOR THE USER ToboDexin 3 mg/g+1 mg/g eye ointment Tobramycin + Dexamethasone

NEVANAC TM 0.1% Eye Drops

PATIENT INFORMATION LEAFLET

Package Leaflet : Information for the User. IOPIDINE 1%w/v eye drops solution (Apraclonidine Hydrochloride)

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. IOPIDINE 1% Apraclonidine Ophthalmic Solution, USP

Package leaflet: Information for the user Pulmicort Respules 0.5 mg, Nebuliser Suspension budesonide

Pilocarpine 2% w/v Eye Drops, solution. Pilocarpine 4% w/v Eye Drops, solution. Pilocarpine Hydrochloride

MAXIDEX TM Eye Ointment 0.1%

1 What Flixonase is and what it is used for

Package leaflet: Information for the patient. Xemacort 20 mg/g + 1 mg/g cream (fusidic acid and betamethasone)

Package leaflet: Information for the user. Catacrom 2 % w/v Eye Drops, Solution. Sodium cromoglicate

2 What you need to know before you use Beconase. Package Leaflet: Information for the user

PATIENT INFORMATION LEAFLET. PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM RELESTAT, epinastine hydrochloride 0,5 mg/ml, eye drops

MURINE HAYFEVER RELIEF 2% W/V EYE DROPS Sodium Cromoglicate

ZADITEN Eye Drops 1.0%

Package leaflet: Information for the user. Xalatan 50 micrograms/ml Eye drops, solution Latanoprost

ALPHAGAN EYE DROPS BRIMONIDINE TARTRATE

BrinzoQuin Eye Drops 1.0%

PATIENT INFORMATION LEAFLET. PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM LUMIGAN 0,01 %, bimatoprost 0,1 mg/ml eye drops

CILOXAN TM Eye Drops 0.3%

PACKAGE LEAFLET: INFORMATION FOR THE USER. XIFAXANTA 200 mg film-coated tablets Rifaximin

What Maxitrol Eye Drops is used for

Package leaflet: Information for the user. Optilamid 10 mg/ml, oogdruppels, suspensie Brinzolamide

Allergy Relief 50 microgram Nasal Spray (Fluticasone propionate)

Package leaflet: Information for the patient. Brinzolamide 10 mg/ml Eye Drops, Suspension brinzolamide

Package leaflet: Information for the user. Latanoprost Pfizer 50 micrograms/ml Eye drops, solution Latanoprost

1. What Miacalcic is and what it is used for

PACKAGE LEAFLET: INFORMATION FOR THE USER. GRAZAX 75,000 SQ-T oral lyophilisate

PACKAGE LEAFLET: INFORMATION FOR THE USER. Dantrium 25 mg Capsules / Dantrium 100 mg Capsules Dantrolene sodium

PACKAGE LEAFLET: INFORMATION FOR THE USER

TAFEN NASAL 50mcg nasal spray, suspension

PATIENT INFORMATION LEAFLET

MAXITROL Eye Ointment

PACKAGE LEAFLET: INFORMATION FOR THE USER Pulmicort Turbohaler budesonide. 1. What Pulmicort Turbohaler is and what it is used for

Package leaflet: Information for the user

TOBREX TM EYE DROPS and EYE OINTMENT 0.3%

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. ILAXTEN 20 MG TABLETS bilastine

Package Leaflet: Information for the User Zofran tablets 4 mg and 8 mg ondansetron (as hydrochloride dihydrate)

Proctosedyl Ointment Hydrocortisone/Cinchocaine hydrochloride/framycetin sulphate/aesculin

Zofran syrup contains a medicine called ondansetron. This belongs to a group of medicines called anti-emetics.

PACKAGE LEAFLET: INFORMATION FOR THE USER Rhinocort Aqua, 64 micrograms, Nasal Spray Budesonide

APO-Olopatadine Eye Drops Contains the active ingredient olopatadine (as olopatadine hydrochloride)

LUMIGAN EYE DROPS (bimatoprost 0.3 mg per ml)

Package leaflet: Information for the user. Bricanyl Respules 2.5 mg/ml Nebuliser Solution terbutaline sulfate

TIMALEN 0.5% eye drops

PATIENT INFORMATION LEAFLET

2 What you need to know before you use Zofran Suppositories

Package leaflet: Information for the user. Zidoval 7.5 mg/g Vaginal Gel Metronidazole

Package leaflet: Information for the patient. Icsori 250 microgram per actuation pressurised inhalation, suspension. fluticasone propionate

Package leaflet: Information for the patient BETAXOLOL 0.5% EYE DROPS. Betaxolol (as hydrochloride)

Package leaflet: Information for the patient. Dymista Nasal Spray 137 micrograms / 50 micrograms per actuation Nasal Spray, Suspension

Package leaflet: Information for the user. SIMBRINZA 10 mg/ml + 2 mg/ml eye drops, suspension Brinzolamide/brimonidine tartrate

Package leaflet: information for the user. OZURDEX 700 micrograms intravitreal implant in applicator dexamethasone

Zofran tablets contain a medicine called ondansetron. This belongs to a group of medicines called anti-emetics.

PACKAGE LEAFLET: INFORMATION FOR THE USER Clotrimazole Cream 1%

Package leaflet: Information for the user

VOLTAREN OPHTHA Eye Drops 0.1%

1. What Octostim Nasal Spray is and what it is used for

PACKAGE LEAFLET: INFORMATION FOR THE USER AMITIZA 24 MICROGRAM SOFT CAPSULES. Lubiprostone

PATIENT INFORMATION LEAFLET

PRESCRIBING INFORMATION AND CONSUMER INFORMATION ISOPTO * CARPINE. pilocarpine hydrochloride ophthalmic solution, USP.

Package leaflet: Information for the user. Elaprase 2 mg/ml concentrate for solution for infusion idursulfase

Package leaflet: Information for the patient UNITED KINGDOM Feldene 5mg/g Gel piroxicam

PACKAGE LEAFLET: INFORMATION FOR THE USER. Otrivin Menthol (without preservative) 1 mg/ml nasal spray, solution Xylometazoline hydrochloride

Some general information on hepatitis A infection is given at the end of this leaflet.

Package leaflet: Information for the user. Fluvastatin

PACKAGE LEAFLET: INFORMATION FOR THE USER

Package leaflet: Information for the user. GANFORT 0.3 mg/ml + 5 mg/ml eye drops, solution Bimatoprost/timolol

Package leaflet: Information for the user. Ebateva 20 mg Orodispersible Tablets. Ebastine

MAXITROL* Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Ointment, USP 3.5 mg (as neomycin sulfate), 6000 IU/g, 0.

PACKAGE LEAFLET: INFORMATION FOR THE USER. DUKORAL suspension and effervescent granules for oral suspension Cholera vaccine (inactivated, oral)

Imodium 1 mg/5 ml oral solution

Package leaflet: Information for the patient. Dexametason Abcur 4 mg tablets. Dexamethasone

Package leaflet: Information for the user. GANFORT 0.3 mg/ml + 5 mg/ml eye drops, solution, in single-dose container Bimatoprost/timolol

ACULAR EYE DROPS 5 mg/ml Eye Drops

Package leaflet: Information for the patient. Plenadren 5 mg modified-release tablets Plenadren 20 mg modified-release tablets Hydrocortisone

FASTUM 2.5% gel PACKAGE LEAFLET: INFORMATION FOR THE USER. What is in this leaflet? 1. WHAT FASTUM GEL IS AND WHAT IT IS USED FOR

PACKAGE LEAFLET: INFORMATION FOR THE USER. SALAGEN 5 mg film-coated tablets. Pilocarpine hydrochloride

Havrix Monodose Vaccine Hepatitis A Vaccine (Inactivated, adsorbed) ELISA Units/1 ml Suspension for Injection in a pre-filled syringe

Transcription:

Package Leaflet - Information for the User TOBRADEX 3 mg/ml/1 mg/ml Eye Drops, Suspension Tobramycin and Dexamethasone Read all of this leaflet carefully before you start using this medicine because it contains important information for you. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or your pharmacist. This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. If you get any side effects talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. In this Patient Information leaflet you will find information about 1. What TOBRADEX is and what it is used for 2. What you need to know before you use TOBRADEX 3. How to use TOBRADEX 4. Possible side effects 5. How to store TOBRADEX 6. Content of the pack and other information 1. What TOBRADEX is and what it is used for TOBRADEX contains dexamethasone a corticosteroid and tobramycin, an antibiotic which is active against a wide range of bacteria that may infect the eye. It is used to prevent and treat inflammation and prevent possible infection of the eye after cataract surgery in adults and children aged 2 years and older. 2. What you need to know before you use TOBRADEX Do not use TOBRADEX... If you have or think that you have any type of infection of the eye. Use of corticosteroids may make infections worse. If you have a sticky discharge from your eye. If you have a red eye that has not been seen by a doctor. If you are allergic to tobramycin or dexamethasone or to any of the other ingredients listed in section 6. If any of these apply ask your doctor for advice. Warnings and precautions If you have a disorder causing a thinning of the eye tissues, such as rheumatoid arthritis, Fuch s dystrophy or following a corneal transplant. Corticosteroids may cause further thinning and possible perforation, and may delay the healing of your eye wound. Topical nonsteroidal anti-inflammatory drugs (NSAIDs) are also known to slow or delay healing. If you use topical NSAIDS and corticosteroids together, it may increase the potential for healing problems. 1

If you experience allergic reactions with TOBRADEX, discontinue use and consult your doctor. Allergic reactions may vary from localized itching or skin redness to severe allergic reactions (anaphylactic reaction) or serious skin reactions. These allergic reactions may occur with other topical or systemic antibiotics of the same family (aminoglycoside type). If your symptoms get worse or suddenly return, please consult your doctor. You may become more susceptible to eye infections with the use of this product. If you are diabetic please consult your doctor. The risk of corticosteroid-induced increase intraocular pressure and / or cataract formation is increased in diabetic patients. Contact your doctor if you experience blurred vision or other visual disturbances. If you are using other antibiotic treatment, including oral, with TOBRADEX, ask your doctor for advice. If you use TOBRADEX for a long period of time, you may become more susceptible to eye infections, have increased pressure in your eye(s) or develop cataracts. Talk to your doctor if you experience swelling and weight gain around the trunk and in the face as these are usually the first manifestations of a syndrome called Cushing s syndrome. Suppression of the adrenal gland function may develop after stopping a long-term or intensive treatment with TOBRADEX. Talk to your doctor before stopping the treatment by yourself. These risks are especially important in children and patients treated with a drug called ritonavir or cobicistat. Signs and symptoms of adrenal suppression include fatigue; light-headedness upon standing or difficulty standing, muscle weakness, fever, weight loss, anxiety, nausea, vomiting, diarrhoea, headache, sweating, changes in mood or personality, and joint and muscle pains. You may still be able to use TOBRADEX, but discuss it with your doctor first. Intraocular pressure should be checked frequently, this is especially important in children below 6 years of age receiving dexamethasone-containing products. Do not give TOBRADEX to children below 2 years old because the safety and efficacy in this population has not been established. Other medicines and TOBRADEX Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. Especially tell your doctor if you are using topical NSAIDs. If you use topical steroids and topical NSAIDs together, it may increase corneal healing problems. Tell your doctor if you are using ritonavir or cobicistat, as this may increase the amount of dexamethasone in the blood. If you are using other eye drops or eye ointments, wait at least 5 minutes between using each one. Eye ointments should be administered last. Pregnancy and breast-feeding If you are pregnant or might get pregnant, or if you are breast-feeding a baby, talk to your doctor before you use TOBRADEX. TOBRADEX is not recommended during pregnancy or breastfeeding. Driving and using machines If you experience temporary blurred vision after using TOBRADEX you should not drive or operate machinery until your vision is clear. Important information if you wear Contact Lenses Contact lens wear is not recommended during treatment of an ocular infection or inflammation. Benzalkonium chloride, used as a preservative in TOBRADEX, may cause eye irritation and discolour soft contact lenses. If you wear soft contact lenses remove them before using TOBRADEX and wait at least 15 minutes before putting them back in. 2

3. How to use TOBRADEX Always use this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure. Only use TOBRADEX for dropping in your eye(s). The usual dose The usual dose is 1 drop in the affected eye(s) every 4 to 6 hours while you are awake. During the initial 48 hours, your doctor may increase the dose to 1 drop every 2 hours. Do not use for more than 24 days. TOBRADEX may be used in children 2 years of age and older at the same dose as in adults. Remove the loose collar from the cap when the bottle is first opened. Always use TOBRADEX exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure. How to use Wash your hands before you start. Shake the bottle well. Twist off the bottle cap. Hold the bottle pointing down, between your thumb and fingers. Tilt your head back. Pull down your lower eyelid with a finger, until there is a pocket between the eyelid and your eye. The drop will go in here (picture 1). Bring the bottle tip close to the eye. Do this in front of a mirror if it helps. Do not touch your eye or eyelid, surrounding areas or other surfaces with the dropper. It could infect the drops. Gently press on the base of the bottle to release one drop at a time (picture 2). Do not squeeze the bottle, only a gentle press on the bottom is needed. After using TOBRADEX, keep the eyelid closed, while simultaneously applying gentle pressure with a finger to the corner of your eye, by the nose for at least 1 minute (picture 3). This helps to limit the amount of medicine that will get into the rest of the body. If you use drops in both eyes, repeat the steps for your other eye. Put the bottle cap firmly back on immediately after use. If a drop misses your eye, try again. If you forget to take TOBRADEX, do not worry, just take it as soon as possible. Do not take a double dose to make up. If you use more TOBRADEX than you should it can be washed out with warm water. 3

If you have any further questions on the use of TOBRADEX, ask your doctor or pharmacist. 4. Possible side effects Like all medicines, TOBRADEX can cause side effects, although not everybody gets them. The following side effects have been seen with TOBRADEX If you notice any of the following possible side effects, stop using this medicine and seek urgent medical advice immediately: itchy rash or hives swelling of the face, lips, tongue or other parts of the body shortness of breath/wheezing severe skin reactions such as blistering which may be accompanied by sore throat, fever or headache The following side effects have also occurred with TOBRADEX: Uncommon side effects (may affect up to 1 in 100 people) Effects in the eye: increased pressure in your eye (s), eye irritation, eye pain, eye itching, watery eyes, eye discomfort. General side effects: headache, runny nose, tightness of the throat. Rare side effects (may affect up to 1 in 1000 people) Effects in the eye: redness, blurred vision, dry eye, eye allergy, eye surface inflammation. General side effects: bad taste. Not known (frequency cannot be estimated from available data) Effects in the eye: increase in pupil size, eyelid redness, eyelid swelling, increased tear production,. General side effects: dizziness, nausea, abdominal discomfort, rash, swelling of the face, itching. Hormone problems: growth of extra body hair (particularly in women), muscle weakness and wasting, purple stretch marks on body skin, increased blood pressure, irregular or missing periods, changes in the levels of protein and calcium in your body, stunted growth in children and teenagers and swelling and weight gain of the body and face (called Cushing s syndrome') (see section 2, Warnings and precautions ). If TOBRADEX is used for more than 24 days, it may cause you to get an infection and the healing of your wound may also be delayed. Reporting of side effects If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system (see details below). By reporting side effects you can help provide more information on the safety of this medicine. 4

United Kingdom Yellow Card Scheme Website: www.mhra.gov.uk/yellowcard 5. How to store TOBRADEX Keep out of the reach and sight of children. This medicinal product does not require any special temperature storage conditions. Keep the bottle tightly closed. Do not use the drops after the expiry date which is stated on the bottle and the carton after Exp:. The expiry date refers to the last day of that month. Stop using the bottle 4 weeks after first opening, to prevent infections. Medicines should not be disposed of via waste water or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment. Do not pass this medicine on to others. It may harm them even if their symptoms are the same as yours. 6. Further information What TOBRADEX contains The active substances are tobramycin 3 mg/ml and dexamethasone 1 mg/ml. The other ingredients are disodium edetate, tyloxapol, sodium chloride, sodium sulphate, hydroxyethylcellulose, benzalkonium chloride, sulphuric acid and/or sodium hydroxide (to adjust ph) and purified water. What TOBRADEX looks like and contents of the pack TOBRADEX is a white to off-white suspension supplied in a pack containing a 5 ml plastic bottle with a screw cap. Marketing authorisation holder: Novartis Pharmaceuticals UK Limited Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR, United Kingdom. Manufacturer: SA Alcon-Couvreur NV Rijksweg 14, B-2870 Puurs, Belgium. This leaflet was last revised in 08/2017 Alcon a Novartis company 5